Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LumiMeds vs Nucore Health

LumiMeds
Graded #143

Higher grade

vs+9.999999999999993
Nucore Health
Graded #367

Lower grade

The verdict

LumiMeds takes it — 68.6/100 to 58.6/100.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +41
77
36
Dose & formulationEven
64
64
Clinical oversightEven
82
82
Labs & monitoringEven
53
53
FulfillmentNucore Health +2
65
67
Contract termsEven
55
55
LumiMeds · left barNucore Health · right bar

The numbers

MetricLumiMedsNucore Health
WeighScore68.6/10058.6/100
GradeCC
Scorecard rank#143#367
Semaglutide$133/mo (starting dose, compounded)$299/mo (starting dose, compounded)
Tirzepatide$133/mo (starting dose, compounded)$199/mo (microdose tier, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
LumiMeds

Graded #143 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Nucore Health

Graded #367 · C

Strengths

  • Physician-owned and LegitScript Certified — strong trust signals
  • Available nationwide in all 50 states
  • Care and pharmacy fulfillment run on OpenLoop Health's licensed network
  • Broad menu — compounded GLP-1, microdose tirzepatide, NAD+, sermorelin, MIC B12

Where it loses points

  • Published pricing is gated behind the intake quiz — no upfront cost shown
  • Legal terms and privacy are posted as downloadable documents, not web pages
  • Compounded GLP-1 is not FDA-approved and prescribed off-label (per their own notice)
  • Longevity and microdose positioning is marketing; evidence varies by use

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard